SlideShare a Scribd company logo
1 of 42
Subhead Calibri 14pt, White
Evaluating the Use of
HPMC Capsule in Drug
Product Development
USP Workshop on Dissolution
Testing of Capsules
March 25, 2014
Alex Deac
Kevin Engh
Jian-Hwa Han*
Bill Huang
Presentation Outline
• Objective
• Background
• Key Areas of Investigation
• Results and Discussion
- In Vitro Evaluation
- Manufacturability Evaluation
- Brittleness Evaluation
- Cost Consideration
• Conclusion and Recommendation
USP Dissolution Workshop, 2014 2
Motivation and Objective
Motivation:
- Limited prior knowledge and experience in using
HPMC capsules for drug product development.
Objective:
- Evaluate physicochemical properties of HPMC capsules
in terms of in-vitro drug release performance and
manufacturability against commonly used Hard Gelatin
Capsule (HGC); identify limitations, if any.
USP Dissolution Workshop, 2014 3
Background:
Main Issues of Hard Gelatin Capsules
High moisture content (13-15%)1
• Brittle in low RH (<12% LOD = <30% RH environment)
• Softening in high RH (>18% LOD = > 70% RH environment)
• Risk of using desiccants due to brittleness
Chemical/Physical stability
• Cross-linking over time (high temp, RH, API/excipients/impurities)
Other Concerns for Global Product
• Animal derived ingredient (Collagen)
• BSE/TSE
1. Sherry Ku M., Li, Weiyi. “Performance Qualification of a New Hypromellose Capsule Part I” Capsugel.
USP Dissolution Workshop, 2014 4
Background:
HPMC vs. Hard Gelatin Capsules – Pro’s
• Low moisture content (2-7%)
~ 13 % to 65% RH environment
• Less hygroscopic (less sensitive to moisture)
• Plant derived
• No Cross-linking concerns
• Suitable for semi-solid matrix and liquid
formulations
• Better for functional coating (e.g. Enteric coating)
USP Dissolution Workshop, 2014 5
Background:
HPMC vs. Hard Gelatin Capsules – Con’s
• Lower film strength at ambient conditions2
• Higher weight variation
• Dissolution issues dependent on the gelling agent used3
• Limited knowledge for in vitro performance, stability,
and manufacturability
• Fewer available vendors
• Risk in switching between vendors due to gelling agents
• Higher unit cost
2. Missaghi, S.,Fassihi, R. “Evaluation and Comparison of Physicomechanical Characteristics of Gelatin and Hypromellose
Capsules”.
3. “Two Piece Gelatine Capsules”. Qualicaps. March, 2013
USP Dissolution Workshop, 2014 6
Key Areas of Investigation
• Part I: In vitro performance evaluation
• Part II: Manufacturability evaluation
• Part III: Brittleness evaluation
• Part IV: Cost comparison
USP Dissolution Workshop, 2014 7
Part I:
In Vitro Drug Release/Dissolution Experimental
• Materials:
Other HPMC capsules also evaluated on paper: Vcaps (Capsugel), Embo Caps VG (Suheung), NatureCaps
(ACG), K-Caps (Caps Canada)
• Dissolution Media:
– Various pH, Ion types, Ion concentration and surfactants
• Dissolution Method:
– USP II (paddle)
– Continuous FO-UV detection on 6 channels
– 900 ml of media
– 75 rpm ( up to 30 min), 200 rpm (>30 min)
– 37 ºC
– N = 6
– Sinker Type:QLA #CAPWHT-TR
Brand Name Manufacturer Type Gelling Agents Short Name
Coni Snap Capsugel Hard Gelatin none HGC
Vcaps Plus Capsugel HPMC none VC+
Quali-V Qualicap HPMC Carrageenan QV
USP Dissolution Workshop, 2014 8
Research Formulation Composition
(for Dissolution Evaluation)
Material Percent
Model compound A (Highly soluble in all
media used)
4.0
Lactose Monohydrate FastFlo #316 57.5
Dibasic Calcium Phosphate, Anhydrous
(FUJICALIN SG)
15.0
Avicel PH-102 15.0
Croscarmellose Sodium 5.0
Hydroxypropyl Cellulose, Vis 10%, 300-600
CPS, Extra Fine
3.0
Magnesium Stearate, (Vegetable Grade) 0.5
USP Dissolution Workshop, 2014 9
10
Dissolution: pH Effect
Credit to Han, Jian-Hwa H.
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
Water pH 4.5
~ pH 1 pH 6.8
Capsule Opening: (Faster) HGC  QV  VC+ (Slower)
USP Dissolution Workshop, 2014 10
Dissolution: Surfactant (SDS, POE and CTAB) Effect
Disolution Comparison in Water
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
Disolution Comparison in 0.5% SDS
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
Disolution Comparison in 0.5% CTAB
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
Disolution Comparison in 0.5% POE10LE
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
Credit to Han, Jian-Hwa H.
QV is
more
sensitive
to CTAB
HGC is
more
sensitive
to SDS
CTAB: Cetyl trimethylammonium bromide; SDS: Sodium dodecyl sulfate; POE: polyoxyethylene lauryl ether
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
Water SDS
POE CTAB
USP Dissolution Workshop, 2014 11
Dissolution: Ionic Effect (Na+ vs. K +)
Disolution Comparison in pH 6.8 Phosphate
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
Disolution Comparison in pH 6.8 Phosphate (K+)
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
50 mM Sodium Phosphate 50 mM Potassium Phosphate
Credit to Han, Jian-Hwa H.
Disolution Comparison in Water
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
HPMC, VC+ HPMC, QV HGC, Gelatin
In Water as Reference
Slower
opening for
QV
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
USP Dissolution Workshop, 2014 12
Impact of Ion Type and Ion Concentration
on QV Dissolution
Ion Type Effect (@50 mM) “Extreme” Ionic condition
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
%LC
Time, Min.
QV Capsule Dissolution Comparison in 0.01N HCl
Na+ vs. K+ vs. Ca++
50 mM NaCl 50 mM KCl
50 mM CaCl2 0.01N HCl
FullRecovery
(@200rpm)
Na+
K+
Ca++
• 50mM KCl
• 150mM NaCl/110mM KCl/15mM CaCl2
• 300mM NaCl/170mM KCl/30mM CaCl2
USP Dissolution Workshop, 2014 13
Effect of Storage Conditions on VC+ Dissolution:
Stability (40ºC/75%RH up to 8 wks)
Capsule 40C/75RH Stability: HPMC VC+ Capsule
(Media = 0.01N HCl)
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 5 10 15 20 25 30 35 40
Time, Min.
%LC
Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks
Capsule 40C/75RH Stability: Hard Gelatin Capsule
(Media = 0.01N HCl)
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 5 10 15 20 25 30 35 40
Time, Min.
%LC
Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks
VC+ VS. HGC
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
It is well known that HGC will show slower dissolution profiles when stored
at 40ºC/75%RH conditions.
Some slowing
down, but no
Impact at 30
minutes.
USP Dissolution Workshop, 2014 14
Effect of Storage Condition on QV Dissolution
Stability (40ºC/75%RH up to 8 wks)
Capsule 40C/75RH Stability: HPMC QV Capsule
(Media = 0.01N HCl)
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 5 10 15 20 25 30 35 40
Time, Min.
%LC
Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks
Capsule 40C/75RH Stability: Hard Gelatin Capsule
(Media = 0.01N HCl)
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 5 10 15 20 25 30 35 40
Time, Min.
%LC
Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks
QV vs. HGC
FullRecovery
(@200rpm)
FullRecovery
(@200rpm)
No Impact.
USP Dissolution Workshop, 2014 15
It is well known that HGC will show slower dissolution profiles when stored
at 40ºC/75%RH conditions.
16
Effect of Storage Condition on Dissolution Stability
Under Low RH (~12%) Condition up to 24 Days
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 5 10 15 20 25 30 35 40
%LC
Time, Min.
Capsule 40C/12RH Stability: Media = 0.01N HCl
VC+ Initial QV Initial HGC Initial
VC+ 24 Days QV 24 Days HGC 24 Days
FullRecovery
(@200rpm)
No difference
after 20 minutes.
USP Dissolution Workshop, 2014
Dissolution: Consistency of HGC Across Different Media
Disolution Comparison - Gelatin HGC Capsule
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
0.1N HCl pH 4.5 pH 6.8 (Na+) Water
pH 6.8 (K+) SDS CTAB POE
Credit to Han, Jian-Hwa H.
FullRecovery
(@200rpm)
SDS
CTAB
USP Dissolution Workshop, 2014 17
Dissolution: Consistency of QV Across Different Media
Disolution Comparison - HPMC QV Capsule
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
0.1N HCl pH 4.5 pH 6.8 (Na+) Water
pH 6.8 (K+) SDS CTAB POE
Credit to Han, Jian-Hwa H.
FullRecovery
(@200rpm)
CTAB
K+
USP Dissolution Workshop, 2014 18
Dissolution: Consistency of VC+ Across Different Media
Disolution Comparison - HPMC VC+ Capsule
0.0
20.0
40.0
60.0
80.0
100.0
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Time, Min.
%LC
0.1N HCl pH 4.5 pH 6.8 (Na+) Water
pH 6.8 (K+) SDS CTAB POE
Credit to Han, Jian-Hwa H.
FullRecovery
(@200rpm)
SDS
USP Dissolution Workshop, 2014 19
Case Study 1:
Fast IR Formulation
20
No difference
after 30 minutes.
USP Dissolution Workshop, 2014
21
Case Study 2:
Complicated Formulation - HGC
Potential Spec Point.
FullRecovery
(@200rpm)
USP Dissolution Workshop, 2014
22
Case Study 2:
Complicated Formulation – HPMC/QV
Potential
Spec Point?
FullRecovery
(@200rpm)
USP Dissolution Workshop, 2014
23
Case Study 2:
Complicated Formulation – HPMC/VC+
Potential Spec
Point???
FullRecovery
(@200rpm)
USP Dissolution Workshop, 2014
Case Study 2:
Complicated Formulation (Mean Profiles, N=6)
24
Significant Impact to
dissolution results.
USP Dissolution Workshop, 2014
Part I: In Vitro Drug Release / Dissolution
Summary
• Longer capsule opening time observed from HPMC capsules.
• With fast releasing formulation, no major dissolution concerns
observed from either HPMC capsule within the normal conditions
tested. However, QV is more sensitive to surfactant (e.g. CTAB) and
Ions, esp. Potassium at higher concentration.
• Both HPMC capsules showed no significant dissolution change
under 40C/75RH open-dish storage.
• No dissolution rate changes observed from storage in low RH for
all capsules (i.e. HGC,QV and VC+).
• For more complicated formulations, thorough evaluation may be
needed before selecting the capsule.
USP Dissolution Workshop, 2014 25
Part II: Manufacturability Evaluation
- Capsule Weight Variability
- Robustness of encapsulation under normal
production condition
USP Dissolution Workshop, 2014 26
Manufacturing: Weight Variability
Capsule Size Mean (mg)
Standard
Deviation (mg)
RSD (%)
00 115.26 2.42 2.10
0 89.06 2.83 3.18
0 (2nd lot) 89.78 2.25 2.50
1 75.08 2.50 3.33
2 60.55 2.24 3.69
4 37.97 1.27 3.35
00 116.73 1.73 1.47
0 93.55 1.16 1.46
0 (2nd lot) 93.81 1.26 1.34
1 75.25 1.08 1.52
2 62.72 0.89 1.29
4 38.11 0.92 2.17
00 125.47 4.38 3.49
0 95.28 2.01 2.11
0 (2nd lot) 94.74 0.78 0.82
1 73.83 0.57 0.77
2 61.46 1.63 2.65
4 37.76 0.99 2.62
Quali-V
HGC
Vcap Plus
N = 500 capsule
USP Dissolution Workshop, 2014 27
28
Encapsulator Bosch GKF 1400; Dosing Disk
Speed 1200 capsules per minute
Running time 40 min (50000 caps)/per run
Weight Checker Bosch KKE 1700
Temperature ~20° C
Humidity 19% and 35% RH
Formulation Avicel PH 101
Weight Checker Limits ± 5% target filled weight
Encapsulation Evaluation
USP Dissolution Workshop, 2014
Capsule
Total
Capsules
Rejected
By Weight
(%)
Mean
Weight
(mg)
Target
Weight
(mg)
Weight
RSD
HGC 68930 0.03 339.2 340 0.71
VC+ 49085 0.54 337.7 340 0.95
VC+ 2nd lot 46836 0.31 337.3 340 1.39
QV 49944 0.00 338.2 340 1.03
QV 2nd lot 50190 0.56 335.7 340 1.25
Lot-to-Lot Variation and Performance of Size 0 HPMC
Capsules Compared to HGC under 35% RH Condition
USP Dissolution Workshop, 2014 29
30
30
Capsule
Total
Capsules
Rejected
By Weight
(%)
Mean
Weight
(mg)
Target
Weight
(mg)
Weight
RSD
HGC 53466 1.38 115.3 115 1.30
VC+ 48750 0.82 114.5 115 1.66
QV 48726 0.11 114.8 115 1.57
Effect of Size 4 Capsules on Rejection Rate and
Weight Variation Under 35% RH
USP Dissolution Workshop, 2014
31
Capsule
Total
Capsules
Rejected
By Weight
(%)
Mean
Weight
(mg)
Target
Weight
(mg)
Weight
RSD
HGC 13549 0.01 341.4 340 0.97
VC+ 24731 0.04 340.5 340 1.20
QV 23984 0.00 334.8 340 1.14
Effect of Low Humidity Conditions (19% RH) on
Rejection Rate and Weight Variation of Size 0 Capsules
Capsules were left to equilibrate to the 19% RH for 3-4 days
USP Dissolution Workshop, 2014
Encapsulation Observations
• No issues regarding rectification, alignment, opening, filling,
closing, and ejecting of either HGC or HPMC capsules during
encapsulation.
• HPMC capsules had a slightly larger weight RSD than HGC.
• Minimal rejects and lot-to-lot variation observed.
• HGC had a shattered capsule in 19% RH conditions. This could
be a potential problem in longer runs. No issues found with
the HPMC capsules.
USP Dissolution Workshop, 2014 32
Part II: Manufacturability Evaluation
Summary
- HGC has an overall better empty capsule weight control
than HPMC capsules, however, both QV and VC+ are still
acceptable with the observed variation.
- Both QV and VC+ have demonstrated acceptable
manufacturability/robustness under normal and lower RH
conditions.
- HPMC capsules also demonstrate better physical and
mechanical properties during the encapsulation process as
well as upon storage.
-HGC and HPMC capsules are comparable in terms of
overall manufacturability.
USP Dissolution Workshop, 2014 33
Part III: Brittleness Evaluation
Method:
• Capsules were stored in bottles, one per type of capsule
• A set of bottles were stored in desiccators that were
subsequently stored in a chamber with controlled
temperature. A second set of capsules were stored at
ambient conditions in the lab.
• Samples were removed to perform tests under ambient
conditions.
• N=10 capsule per weight drop
USP Dissolution Workshop, 2014 34
Brittleness Evaluation – Impact Tester
Equipment Used:
Impact Tester
Hollow tube with a
height of ~2 feet through
which a weight pellet
can be dropped onto a
capsule held in place at
the bottom of the tube
by a capsule holder.
USP Dissolution Workshop, 2014 35
36
Part III: Brittleness Evaluation
Results and Summary
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60
PercentBrokenoutof10
Weight Dropped From 30.25 Inches (g)
Capsule Shell Resistance to Impact at ~22 C° and 35-55% RH
Hard Gelatin
Vcap Plus
Quali-V
0
20
40
60
80
100
0 10 20 30 40 50 60
PercentBrokenoutof10
Weight Dropped From 30.25 Inches (g)
Capsule Shell Resistance to Impact at 40°C and 25% RH for 83 Days
Hard Gelatin
Vcap Plus
Quali-V
HGC becomes more brittle under hi-temp and low humidity condition over
time.
USP Dissolution Workshop, 2014
Part III: Cost Evaluation
HGC: ~
HPMC: ~
37USP Dissolution Workshop, 2014
Conclusion and Recommendation
- Both HPMC capsules (i.e. QV and VC+) fit for
Oral Drug Development.
- HPMC capsules are generally not recommended
due to the cost concerns relative to HGC.
- If HPMC capsule will be used, a thorough
evaluation is recommended to make sure the
overall performance meets expectations.
USP Dissolution Workshop, 2014 38
• The design, study conduct, and financial support for the
study were provided by Abbvie. Abbvie participated in
the interpretation of data, review, and approval of the
presentation.
• Abbvie is the sole source of funding for the related
studies in this presentation. No other entity has
provided any funding for the related studies in this
presentation.
Disclosures
USP Dissolution Workshop, 2014 39
Acknowledgement
• Dr. Jian-Hwa Han is employed at Abbvie. Dr. Han planned and
executed the dissolution experiments for this study.
• Dr. Ye Huang is employed at Abbvie. Dr. Huang was the primary
investigator for this study.
• Mr. Alexandru Deac is employed at Abbvie. Mr. Deac was the key
formulator for this study.
• Mr. Kevin Engh is employed at Abbvie. Mr. Engh was the process
engineer for this study.
• Dr. Gregory K. Webster and Dr. Paul D. Curry, Jr. are employed at
Abbvie who contributed to scientific discussions and reviewed the
presentation materials.
40USP Dissolution Workshop, 2014
Q&A
HPMC Capsule_USP Workshop_2014 Final

More Related Content

What's hot

plastic and glass containers and its evaluation test, drug plastic considera...
plastic  and glass containers and its evaluation test, drug plastic considera...plastic  and glass containers and its evaluation test, drug plastic considera...
plastic and glass containers and its evaluation test, drug plastic considera...SUJIT DAS
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packagingTeny Thomas
 
M pharm taste masking techniques
M pharm taste masking  techniquesM pharm taste masking  techniques
M pharm taste masking techniquesQazi Saifullah
 
Tablets; General Introduction & Classification ;_By Tejas Bhatia.
Tablets; General Introduction & Classification ;_By Tejas Bhatia.Tablets; General Introduction & Classification ;_By Tejas Bhatia.
Tablets; General Introduction & Classification ;_By Tejas Bhatia.TejasBhatia2
 
Zaocare Detailed Brochure.pdf
Zaocare Detailed Brochure.pdfZaocare Detailed Brochure.pdf
Zaocare Detailed Brochure.pdfZaocare
 
Packaging, Labeling and Artwork Management
Packaging, Labeling and Artwork ManagementPackaging, Labeling and Artwork Management
Packaging, Labeling and Artwork ManagementVedant Borse
 
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshareAsgharullahKhan
 
Ipqc tests for tablets
Ipqc tests for tabletsIpqc tests for tablets
Ipqc tests for tabletsAMIT KANSE
 
In process quality control of suspensions and emulsions
In process quality control of suspensions and emulsionsIn process quality control of suspensions and emulsions
In process quality control of suspensions and emulsionsceutics1315
 

What's hot (20)

Tabletcoating
TabletcoatingTabletcoating
Tabletcoating
 
Pharma Packaging
Pharma PackagingPharma Packaging
Pharma Packaging
 
plastic and glass containers and its evaluation test, drug plastic considera...
plastic  and glass containers and its evaluation test, drug plastic considera...plastic  and glass containers and its evaluation test, drug plastic considera...
plastic and glass containers and its evaluation test, drug plastic considera...
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packaging
 
M pharm taste masking techniques
M pharm taste masking  techniquesM pharm taste masking  techniques
M pharm taste masking techniques
 
Tablets
Tablets Tablets
Tablets
 
Shashank Jain
Shashank JainShashank Jain
Shashank Jain
 
Tablets; General Introduction & Classification ;_By Tejas Bhatia.
Tablets; General Introduction & Classification ;_By Tejas Bhatia.Tablets; General Introduction & Classification ;_By Tejas Bhatia.
Tablets; General Introduction & Classification ;_By Tejas Bhatia.
 
Zaocare Detailed Brochure.pdf
Zaocare Detailed Brochure.pdfZaocare Detailed Brochure.pdf
Zaocare Detailed Brochure.pdf
 
Packaging, Labeling and Artwork Management
Packaging, Labeling and Artwork ManagementPackaging, Labeling and Artwork Management
Packaging, Labeling and Artwork Management
 
Tablets
TabletsTablets
Tablets
 
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshare
 
Excipients sb
Excipients sbExcipients sb
Excipients sb
 
Ipqc tests for tablets
Ipqc tests for tabletsIpqc tests for tablets
Ipqc tests for tablets
 
Quality Control Tests for Ophthalmics
Quality Control Tests for OphthalmicsQuality Control Tests for Ophthalmics
Quality Control Tests for Ophthalmics
 
Pelletization
PelletizationPelletization
Pelletization
 
In process quality control of suspensions and emulsions
In process quality control of suspensions and emulsionsIn process quality control of suspensions and emulsions
In process quality control of suspensions and emulsions
 
Liquid dosage form monophsaic
Liquid dosage form monophsaicLiquid dosage form monophsaic
Liquid dosage form monophsaic
 
Pharmaceutical Sweeteners
Pharmaceutical SweetenersPharmaceutical Sweeteners
Pharmaceutical Sweeteners
 
Capsules
CapsulesCapsules
Capsules
 

Viewers also liked

dip coating
dip coatingdip coating
dip coatingengrktk
 
Project "Pectins"
Project "Pectins"Project "Pectins"
Project "Pectins"Ivan Bozhko
 
Stdf pectin, presentation
Stdf pectin, presentationStdf pectin, presentation
Stdf pectin, presentationAmr Helal
 
Hard gelatin capsules
Hard gelatin capsulesHard gelatin capsules
Hard gelatin capsuleshussanrocks
 
Taste masking approaches
Taste masking approachesTaste masking approaches
Taste masking approachesbhandarisaurav
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of DissolutionPRASHANT DEORE
 
Capsule and its annovation
Capsule and its annovationCapsule and its annovation
Capsule and its annovationVijay Gajera
 
Drug release and dissolution
Drug release and dissolution Drug release and dissolution
Drug release and dissolution Areej Abu Hanieh
 
Sistema operativo elizabeth aguilar
Sistema operativo elizabeth aguilarSistema operativo elizabeth aguilar
Sistema operativo elizabeth aguilarelizatlv29
 
Presentation1 (2)
Presentation1 (2)Presentation1 (2)
Presentation1 (2)mam141931
 
Presentation1 ict based lesson plan
Presentation1 ict based lesson planPresentation1 ict based lesson plan
Presentation1 ict based lesson planaswathyr7
 
Ashley Adams
Ashley AdamsAshley Adams
Ashley AdamsAsh Adams
 
Adapting a Lesson Plan
Adapting a Lesson PlanAdapting a Lesson Plan
Adapting a Lesson PlanJoe Dillon
 
Gift Guide 2015 - William Penn
Gift Guide 2015 - William PennGift Guide 2015 - William Penn
Gift Guide 2015 - William Pennrishey067
 
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñoz
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñozFp fm reporte aplicacion aamtic_g89_act.2-angelap.muñoz
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñozAngelaPatyMunoz
 

Viewers also liked (20)

dip coating
dip coatingdip coating
dip coating
 
Project "Pectins"
Project "Pectins"Project "Pectins"
Project "Pectins"
 
Stdf pectin, presentation
Stdf pectin, presentationStdf pectin, presentation
Stdf pectin, presentation
 
HPMC 2014 - The value of analytics - SAS
HPMC 2014 - The value of analytics - SASHPMC 2014 - The value of analytics - SAS
HPMC 2014 - The value of analytics - SAS
 
Hard gelatin capsules
Hard gelatin capsulesHard gelatin capsules
Hard gelatin capsules
 
Taste masking approaches
Taste masking approachesTaste masking approaches
Taste masking approaches
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 
Capsule and its annovation
Capsule and its annovationCapsule and its annovation
Capsule and its annovation
 
Cellulose and it's properties
Cellulose and it's propertiesCellulose and it's properties
Cellulose and it's properties
 
Drug release and dissolution
Drug release and dissolution Drug release and dissolution
Drug release and dissolution
 
Sistema operativo elizabeth aguilar
Sistema operativo elizabeth aguilarSistema operativo elizabeth aguilar
Sistema operativo elizabeth aguilar
 
Presentation1 (2)
Presentation1 (2)Presentation1 (2)
Presentation1 (2)
 
Presentation1 ict based lesson plan
Presentation1 ict based lesson planPresentation1 ict based lesson plan
Presentation1 ict based lesson plan
 
Public Squash Foundation
Public Squash FoundationPublic Squash Foundation
Public Squash Foundation
 
Ashley Adams
Ashley AdamsAshley Adams
Ashley Adams
 
Cv dejan kovachovski
Cv dejan kovachovskiCv dejan kovachovski
Cv dejan kovachovski
 
Adapting a Lesson Plan
Adapting a Lesson PlanAdapting a Lesson Plan
Adapting a Lesson Plan
 
Art
ArtArt
Art
 
Gift Guide 2015 - William Penn
Gift Guide 2015 - William PennGift Guide 2015 - William Penn
Gift Guide 2015 - William Penn
 
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñoz
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñozFp fm reporte aplicacion aamtic_g89_act.2-angelap.muñoz
Fp fm reporte aplicacion aamtic_g89_act.2-angelap.muñoz
 

Similar to HPMC Capsule_USP Workshop_2014 Final

Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Md. Saddam Nawaz
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddyceutics1315
 
Developing specifications q3 q6
Developing specifications  q3 q6Developing specifications  q3 q6
Developing specifications q3 q6NamrataBawaskar
 
Floating multiparticulate delivery system of lamivudine
Floating multiparticulate delivery system of lamivudineFloating multiparticulate delivery system of lamivudine
Floating multiparticulate delivery system of lamivudineProf. (Dr.) Pal
 
In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
 
Biomass Flocculation Study_IP-Free
Biomass Flocculation Study_IP-FreeBiomass Flocculation Study_IP-Free
Biomass Flocculation Study_IP-FreeKirk Oler
 
GUIDELINES FOR DISSOLUTION TESTING
GUIDELINES FOR DISSOLUTION TESTINGGUIDELINES FOR DISSOLUTION TESTING
GUIDELINES FOR DISSOLUTION TESTINGSagar Savale
 
Pharmacosome of rosuvastatin
Pharmacosome of rosuvastatinPharmacosome of rosuvastatin
Pharmacosome of rosuvastatinProf. (Dr.) Pal
 
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENT
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENTDRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENT
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENTRoshan Sonkar
 
Dissolution_Technique.ppt
Dissolution_Technique.pptDissolution_Technique.ppt
Dissolution_Technique.pptRavi Kumar G
 
Oligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesOligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesPine Lake Laboratories
 
Seminar on evaluation of floating tablets.
Seminar on evaluation of floating tablets.Seminar on evaluation of floating tablets.
Seminar on evaluation of floating tablets.sushiv
 
PattersonEWRI2014 (1)
PattersonEWRI2014 (1)PattersonEWRI2014 (1)
PattersonEWRI2014 (1)John Maziuk
 
Stability_Indicating_HPLC_Method.ppt
Stability_Indicating_HPLC_Method.pptStability_Indicating_HPLC_Method.ppt
Stability_Indicating_HPLC_Method.pptRavi Kumar G
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...MilliporeSigma
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Merck Life Sciences
 

Similar to HPMC Capsule_USP Workshop_2014 Final (20)

USP EP Meeting_2013 Final
USP EP Meeting_2013 FinalUSP EP Meeting_2013 Final
USP EP Meeting_2013 Final
 
Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddy
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddy
 
Developing specifications q3 q6
Developing specifications  q3 q6Developing specifications  q3 q6
Developing specifications q3 q6
 
Rajaguru ppt
Rajaguru pptRajaguru ppt
Rajaguru ppt
 
Floating multiparticulate delivery system of lamivudine
Floating multiparticulate delivery system of lamivudineFloating multiparticulate delivery system of lamivudine
Floating multiparticulate delivery system of lamivudine
 
In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage From
 
Biomass Flocculation Study_IP-Free
Biomass Flocculation Study_IP-FreeBiomass Flocculation Study_IP-Free
Biomass Flocculation Study_IP-Free
 
Dissolution
DissolutionDissolution
Dissolution
 
GUIDELINES FOR DISSOLUTION TESTING
GUIDELINES FOR DISSOLUTION TESTINGGUIDELINES FOR DISSOLUTION TESTING
GUIDELINES FOR DISSOLUTION TESTING
 
Pharmacosome of rosuvastatin
Pharmacosome of rosuvastatinPharmacosome of rosuvastatin
Pharmacosome of rosuvastatin
 
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENT
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENTDRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENT
DRUG DISSOLUTION, BIO-AVAILABILITY AND IVIVC DEVELOPMENT
 
Dissolution_Technique.ppt
Dissolution_Technique.pptDissolution_Technique.ppt
Dissolution_Technique.ppt
 
Oligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesOligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake Laboratories
 
Seminar on evaluation of floating tablets.
Seminar on evaluation of floating tablets.Seminar on evaluation of floating tablets.
Seminar on evaluation of floating tablets.
 
PattersonEWRI2014 (1)
PattersonEWRI2014 (1)PattersonEWRI2014 (1)
PattersonEWRI2014 (1)
 
Stability_Indicating_HPLC_Method.ppt
Stability_Indicating_HPLC_Method.pptStability_Indicating_HPLC_Method.ppt
Stability_Indicating_HPLC_Method.ppt
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
 
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formul...
 

More from Jian-Hwa Han 韓建華

More from Jian-Hwa Han 韓建華 (6)

Stimuli PF 40 6 final
Stimuli PF 40 6 finalStimuli PF 40 6 final
Stimuli PF 40 6 final
 
USP Workshop posters_090815 XS, JHH, GW
USP Workshop posters_090815 XS, JHH, GWUSP Workshop posters_090815 XS, JHH, GW
USP Workshop posters_090815 XS, JHH, GW
 
EAS 2015 Disso Presentation_JHH_final
EAS 2015 Disso Presentation_JHH_finalEAS 2015 Disso Presentation_JHH_final
EAS 2015 Disso Presentation_JHH_final
 
USP Disso_Bazil 2013_Spec v6
USP Disso_Bazil 2013_Spec v6USP Disso_Bazil 2013_Spec v6
USP Disso_Bazil 2013_Spec v6
 
USP_Disso_Bazil_2013_Method_Final2
USP_Disso_Bazil_2013_Method_Final2USP_Disso_Bazil_2013_Method_Final2
USP_Disso_Bazil_2013_Method_Final2
 
USP Disso Workshop_Tier 2 Method_JHH 11Jun2012 Final v3
USP Disso Workshop_Tier 2 Method_JHH 11Jun2012 Final v3USP Disso Workshop_Tier 2 Method_JHH 11Jun2012 Final v3
USP Disso Workshop_Tier 2 Method_JHH 11Jun2012 Final v3
 

HPMC Capsule_USP Workshop_2014 Final

  • 1. Subhead Calibri 14pt, White Evaluating the Use of HPMC Capsule in Drug Product Development USP Workshop on Dissolution Testing of Capsules March 25, 2014 Alex Deac Kevin Engh Jian-Hwa Han* Bill Huang
  • 2. Presentation Outline • Objective • Background • Key Areas of Investigation • Results and Discussion - In Vitro Evaluation - Manufacturability Evaluation - Brittleness Evaluation - Cost Consideration • Conclusion and Recommendation USP Dissolution Workshop, 2014 2
  • 3. Motivation and Objective Motivation: - Limited prior knowledge and experience in using HPMC capsules for drug product development. Objective: - Evaluate physicochemical properties of HPMC capsules in terms of in-vitro drug release performance and manufacturability against commonly used Hard Gelatin Capsule (HGC); identify limitations, if any. USP Dissolution Workshop, 2014 3
  • 4. Background: Main Issues of Hard Gelatin Capsules High moisture content (13-15%)1 • Brittle in low RH (<12% LOD = <30% RH environment) • Softening in high RH (>18% LOD = > 70% RH environment) • Risk of using desiccants due to brittleness Chemical/Physical stability • Cross-linking over time (high temp, RH, API/excipients/impurities) Other Concerns for Global Product • Animal derived ingredient (Collagen) • BSE/TSE 1. Sherry Ku M., Li, Weiyi. “Performance Qualification of a New Hypromellose Capsule Part I” Capsugel. USP Dissolution Workshop, 2014 4
  • 5. Background: HPMC vs. Hard Gelatin Capsules – Pro’s • Low moisture content (2-7%) ~ 13 % to 65% RH environment • Less hygroscopic (less sensitive to moisture) • Plant derived • No Cross-linking concerns • Suitable for semi-solid matrix and liquid formulations • Better for functional coating (e.g. Enteric coating) USP Dissolution Workshop, 2014 5
  • 6. Background: HPMC vs. Hard Gelatin Capsules – Con’s • Lower film strength at ambient conditions2 • Higher weight variation • Dissolution issues dependent on the gelling agent used3 • Limited knowledge for in vitro performance, stability, and manufacturability • Fewer available vendors • Risk in switching between vendors due to gelling agents • Higher unit cost 2. Missaghi, S.,Fassihi, R. “Evaluation and Comparison of Physicomechanical Characteristics of Gelatin and Hypromellose Capsules”. 3. “Two Piece Gelatine Capsules”. Qualicaps. March, 2013 USP Dissolution Workshop, 2014 6
  • 7. Key Areas of Investigation • Part I: In vitro performance evaluation • Part II: Manufacturability evaluation • Part III: Brittleness evaluation • Part IV: Cost comparison USP Dissolution Workshop, 2014 7
  • 8. Part I: In Vitro Drug Release/Dissolution Experimental • Materials: Other HPMC capsules also evaluated on paper: Vcaps (Capsugel), Embo Caps VG (Suheung), NatureCaps (ACG), K-Caps (Caps Canada) • Dissolution Media: – Various pH, Ion types, Ion concentration and surfactants • Dissolution Method: – USP II (paddle) – Continuous FO-UV detection on 6 channels – 900 ml of media – 75 rpm ( up to 30 min), 200 rpm (>30 min) – 37 ºC – N = 6 – Sinker Type:QLA #CAPWHT-TR Brand Name Manufacturer Type Gelling Agents Short Name Coni Snap Capsugel Hard Gelatin none HGC Vcaps Plus Capsugel HPMC none VC+ Quali-V Qualicap HPMC Carrageenan QV USP Dissolution Workshop, 2014 8
  • 9. Research Formulation Composition (for Dissolution Evaluation) Material Percent Model compound A (Highly soluble in all media used) 4.0 Lactose Monohydrate FastFlo #316 57.5 Dibasic Calcium Phosphate, Anhydrous (FUJICALIN SG) 15.0 Avicel PH-102 15.0 Croscarmellose Sodium 5.0 Hydroxypropyl Cellulose, Vis 10%, 300-600 CPS, Extra Fine 3.0 Magnesium Stearate, (Vegetable Grade) 0.5 USP Dissolution Workshop, 2014 9
  • 10. 10 Dissolution: pH Effect Credit to Han, Jian-Hwa H. FullRecovery (@200rpm) FullRecovery (@200rpm) FullRecovery (@200rpm) FullRecovery (@200rpm) Water pH 4.5 ~ pH 1 pH 6.8 Capsule Opening: (Faster) HGC  QV  VC+ (Slower) USP Dissolution Workshop, 2014 10
  • 11. Dissolution: Surfactant (SDS, POE and CTAB) Effect Disolution Comparison in Water 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin Disolution Comparison in 0.5% SDS 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin Disolution Comparison in 0.5% CTAB 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin Disolution Comparison in 0.5% POE10LE 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin Credit to Han, Jian-Hwa H. QV is more sensitive to CTAB HGC is more sensitive to SDS CTAB: Cetyl trimethylammonium bromide; SDS: Sodium dodecyl sulfate; POE: polyoxyethylene lauryl ether FullRecovery (@200rpm) FullRecovery (@200rpm) FullRecovery (@200rpm) FullRecovery (@200rpm) Water SDS POE CTAB USP Dissolution Workshop, 2014 11
  • 12. Dissolution: Ionic Effect (Na+ vs. K +) Disolution Comparison in pH 6.8 Phosphate 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin Disolution Comparison in pH 6.8 Phosphate (K+) 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin 50 mM Sodium Phosphate 50 mM Potassium Phosphate Credit to Han, Jian-Hwa H. Disolution Comparison in Water 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC HPMC, VC+ HPMC, QV HGC, Gelatin In Water as Reference Slower opening for QV FullRecovery (@200rpm) FullRecovery (@200rpm) FullRecovery (@200rpm) USP Dissolution Workshop, 2014 12
  • 13. Impact of Ion Type and Ion Concentration on QV Dissolution Ion Type Effect (@50 mM) “Extreme” Ionic condition 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 %LC Time, Min. QV Capsule Dissolution Comparison in 0.01N HCl Na+ vs. K+ vs. Ca++ 50 mM NaCl 50 mM KCl 50 mM CaCl2 0.01N HCl FullRecovery (@200rpm) Na+ K+ Ca++ • 50mM KCl • 150mM NaCl/110mM KCl/15mM CaCl2 • 300mM NaCl/170mM KCl/30mM CaCl2 USP Dissolution Workshop, 2014 13
  • 14. Effect of Storage Conditions on VC+ Dissolution: Stability (40ºC/75%RH up to 8 wks) Capsule 40C/75RH Stability: HPMC VC+ Capsule (Media = 0.01N HCl) 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0 5 10 15 20 25 30 35 40 Time, Min. %LC Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks Capsule 40C/75RH Stability: Hard Gelatin Capsule (Media = 0.01N HCl) 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0 5 10 15 20 25 30 35 40 Time, Min. %LC Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks VC+ VS. HGC FullRecovery (@200rpm) FullRecovery (@200rpm) It is well known that HGC will show slower dissolution profiles when stored at 40ºC/75%RH conditions. Some slowing down, but no Impact at 30 minutes. USP Dissolution Workshop, 2014 14
  • 15. Effect of Storage Condition on QV Dissolution Stability (40ºC/75%RH up to 8 wks) Capsule 40C/75RH Stability: HPMC QV Capsule (Media = 0.01N HCl) 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0 5 10 15 20 25 30 35 40 Time, Min. %LC Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks Capsule 40C/75RH Stability: Hard Gelatin Capsule (Media = 0.01N HCl) 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0 5 10 15 20 25 30 35 40 Time, Min. %LC Initial 1 week 2 weeks 4 weeks 6 weeks 8 weeks QV vs. HGC FullRecovery (@200rpm) FullRecovery (@200rpm) No Impact. USP Dissolution Workshop, 2014 15 It is well known that HGC will show slower dissolution profiles when stored at 40ºC/75%RH conditions.
  • 16. 16 Effect of Storage Condition on Dissolution Stability Under Low RH (~12%) Condition up to 24 Days 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0 5 10 15 20 25 30 35 40 %LC Time, Min. Capsule 40C/12RH Stability: Media = 0.01N HCl VC+ Initial QV Initial HGC Initial VC+ 24 Days QV 24 Days HGC 24 Days FullRecovery (@200rpm) No difference after 20 minutes. USP Dissolution Workshop, 2014
  • 17. Dissolution: Consistency of HGC Across Different Media Disolution Comparison - Gelatin HGC Capsule 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC 0.1N HCl pH 4.5 pH 6.8 (Na+) Water pH 6.8 (K+) SDS CTAB POE Credit to Han, Jian-Hwa H. FullRecovery (@200rpm) SDS CTAB USP Dissolution Workshop, 2014 17
  • 18. Dissolution: Consistency of QV Across Different Media Disolution Comparison - HPMC QV Capsule 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC 0.1N HCl pH 4.5 pH 6.8 (Na+) Water pH 6.8 (K+) SDS CTAB POE Credit to Han, Jian-Hwa H. FullRecovery (@200rpm) CTAB K+ USP Dissolution Workshop, 2014 18
  • 19. Dissolution: Consistency of VC+ Across Different Media Disolution Comparison - HPMC VC+ Capsule 0.0 20.0 40.0 60.0 80.0 100.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Time, Min. %LC 0.1N HCl pH 4.5 pH 6.8 (Na+) Water pH 6.8 (K+) SDS CTAB POE Credit to Han, Jian-Hwa H. FullRecovery (@200rpm) SDS USP Dissolution Workshop, 2014 19
  • 20. Case Study 1: Fast IR Formulation 20 No difference after 30 minutes. USP Dissolution Workshop, 2014
  • 21. 21 Case Study 2: Complicated Formulation - HGC Potential Spec Point. FullRecovery (@200rpm) USP Dissolution Workshop, 2014
  • 22. 22 Case Study 2: Complicated Formulation – HPMC/QV Potential Spec Point? FullRecovery (@200rpm) USP Dissolution Workshop, 2014
  • 23. 23 Case Study 2: Complicated Formulation – HPMC/VC+ Potential Spec Point??? FullRecovery (@200rpm) USP Dissolution Workshop, 2014
  • 24. Case Study 2: Complicated Formulation (Mean Profiles, N=6) 24 Significant Impact to dissolution results. USP Dissolution Workshop, 2014
  • 25. Part I: In Vitro Drug Release / Dissolution Summary • Longer capsule opening time observed from HPMC capsules. • With fast releasing formulation, no major dissolution concerns observed from either HPMC capsule within the normal conditions tested. However, QV is more sensitive to surfactant (e.g. CTAB) and Ions, esp. Potassium at higher concentration. • Both HPMC capsules showed no significant dissolution change under 40C/75RH open-dish storage. • No dissolution rate changes observed from storage in low RH for all capsules (i.e. HGC,QV and VC+). • For more complicated formulations, thorough evaluation may be needed before selecting the capsule. USP Dissolution Workshop, 2014 25
  • 26. Part II: Manufacturability Evaluation - Capsule Weight Variability - Robustness of encapsulation under normal production condition USP Dissolution Workshop, 2014 26
  • 27. Manufacturing: Weight Variability Capsule Size Mean (mg) Standard Deviation (mg) RSD (%) 00 115.26 2.42 2.10 0 89.06 2.83 3.18 0 (2nd lot) 89.78 2.25 2.50 1 75.08 2.50 3.33 2 60.55 2.24 3.69 4 37.97 1.27 3.35 00 116.73 1.73 1.47 0 93.55 1.16 1.46 0 (2nd lot) 93.81 1.26 1.34 1 75.25 1.08 1.52 2 62.72 0.89 1.29 4 38.11 0.92 2.17 00 125.47 4.38 3.49 0 95.28 2.01 2.11 0 (2nd lot) 94.74 0.78 0.82 1 73.83 0.57 0.77 2 61.46 1.63 2.65 4 37.76 0.99 2.62 Quali-V HGC Vcap Plus N = 500 capsule USP Dissolution Workshop, 2014 27
  • 28. 28 Encapsulator Bosch GKF 1400; Dosing Disk Speed 1200 capsules per minute Running time 40 min (50000 caps)/per run Weight Checker Bosch KKE 1700 Temperature ~20° C Humidity 19% and 35% RH Formulation Avicel PH 101 Weight Checker Limits ± 5% target filled weight Encapsulation Evaluation USP Dissolution Workshop, 2014
  • 29. Capsule Total Capsules Rejected By Weight (%) Mean Weight (mg) Target Weight (mg) Weight RSD HGC 68930 0.03 339.2 340 0.71 VC+ 49085 0.54 337.7 340 0.95 VC+ 2nd lot 46836 0.31 337.3 340 1.39 QV 49944 0.00 338.2 340 1.03 QV 2nd lot 50190 0.56 335.7 340 1.25 Lot-to-Lot Variation and Performance of Size 0 HPMC Capsules Compared to HGC under 35% RH Condition USP Dissolution Workshop, 2014 29
  • 30. 30 30 Capsule Total Capsules Rejected By Weight (%) Mean Weight (mg) Target Weight (mg) Weight RSD HGC 53466 1.38 115.3 115 1.30 VC+ 48750 0.82 114.5 115 1.66 QV 48726 0.11 114.8 115 1.57 Effect of Size 4 Capsules on Rejection Rate and Weight Variation Under 35% RH USP Dissolution Workshop, 2014
  • 31. 31 Capsule Total Capsules Rejected By Weight (%) Mean Weight (mg) Target Weight (mg) Weight RSD HGC 13549 0.01 341.4 340 0.97 VC+ 24731 0.04 340.5 340 1.20 QV 23984 0.00 334.8 340 1.14 Effect of Low Humidity Conditions (19% RH) on Rejection Rate and Weight Variation of Size 0 Capsules Capsules were left to equilibrate to the 19% RH for 3-4 days USP Dissolution Workshop, 2014
  • 32. Encapsulation Observations • No issues regarding rectification, alignment, opening, filling, closing, and ejecting of either HGC or HPMC capsules during encapsulation. • HPMC capsules had a slightly larger weight RSD than HGC. • Minimal rejects and lot-to-lot variation observed. • HGC had a shattered capsule in 19% RH conditions. This could be a potential problem in longer runs. No issues found with the HPMC capsules. USP Dissolution Workshop, 2014 32
  • 33. Part II: Manufacturability Evaluation Summary - HGC has an overall better empty capsule weight control than HPMC capsules, however, both QV and VC+ are still acceptable with the observed variation. - Both QV and VC+ have demonstrated acceptable manufacturability/robustness under normal and lower RH conditions. - HPMC capsules also demonstrate better physical and mechanical properties during the encapsulation process as well as upon storage. -HGC and HPMC capsules are comparable in terms of overall manufacturability. USP Dissolution Workshop, 2014 33
  • 34. Part III: Brittleness Evaluation Method: • Capsules were stored in bottles, one per type of capsule • A set of bottles were stored in desiccators that were subsequently stored in a chamber with controlled temperature. A second set of capsules were stored at ambient conditions in the lab. • Samples were removed to perform tests under ambient conditions. • N=10 capsule per weight drop USP Dissolution Workshop, 2014 34
  • 35. Brittleness Evaluation – Impact Tester Equipment Used: Impact Tester Hollow tube with a height of ~2 feet through which a weight pellet can be dropped onto a capsule held in place at the bottom of the tube by a capsule holder. USP Dissolution Workshop, 2014 35
  • 36. 36 Part III: Brittleness Evaluation Results and Summary 0 10 20 30 40 50 60 70 80 90 100 0 10 20 30 40 50 60 PercentBrokenoutof10 Weight Dropped From 30.25 Inches (g) Capsule Shell Resistance to Impact at ~22 C° and 35-55% RH Hard Gelatin Vcap Plus Quali-V 0 20 40 60 80 100 0 10 20 30 40 50 60 PercentBrokenoutof10 Weight Dropped From 30.25 Inches (g) Capsule Shell Resistance to Impact at 40°C and 25% RH for 83 Days Hard Gelatin Vcap Plus Quali-V HGC becomes more brittle under hi-temp and low humidity condition over time. USP Dissolution Workshop, 2014
  • 37. Part III: Cost Evaluation HGC: ~ HPMC: ~ 37USP Dissolution Workshop, 2014
  • 38. Conclusion and Recommendation - Both HPMC capsules (i.e. QV and VC+) fit for Oral Drug Development. - HPMC capsules are generally not recommended due to the cost concerns relative to HGC. - If HPMC capsule will be used, a thorough evaluation is recommended to make sure the overall performance meets expectations. USP Dissolution Workshop, 2014 38
  • 39. • The design, study conduct, and financial support for the study were provided by Abbvie. Abbvie participated in the interpretation of data, review, and approval of the presentation. • Abbvie is the sole source of funding for the related studies in this presentation. No other entity has provided any funding for the related studies in this presentation. Disclosures USP Dissolution Workshop, 2014 39
  • 40. Acknowledgement • Dr. Jian-Hwa Han is employed at Abbvie. Dr. Han planned and executed the dissolution experiments for this study. • Dr. Ye Huang is employed at Abbvie. Dr. Huang was the primary investigator for this study. • Mr. Alexandru Deac is employed at Abbvie. Mr. Deac was the key formulator for this study. • Mr. Kevin Engh is employed at Abbvie. Mr. Engh was the process engineer for this study. • Dr. Gregory K. Webster and Dr. Paul D. Curry, Jr. are employed at Abbvie who contributed to scientific discussions and reviewed the presentation materials. 40USP Dissolution Workshop, 2014
  • 41. Q&A